Tang, Bo <br/><br/>
Enhanced autophagy by everolimus contributes to the antirestenotic mechanisms in vascular smooth muscle cells.  [electronic resource] 

 -  Journal of vascular research  2014 
 - 259-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0135 
<br/><br/><label>Standard No.: </label>10.1159/000365927  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta, Thoracic--cytology<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Carrier Proteins--metabolism<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>Everolimus<br/>Immunosuppressive Agents--pharmacology<br/>Intracellular Signaling Peptides and Proteins<br/>Male<br/>Muscle, Smooth, Vascular--cytology<br/>Phosphoproteins--metabolism<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>RNA, Small Interfering--genetics<br/>Rats, Wistar<br/>Ribosomal Protein S6 Kinases--metabolism<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Vascular Resistance--drug effects